Antonios Aliprantis is a Rheumatology/Immunology physician. OpenAlex indexes 92 publications with 8,639 citations (h-index 40).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
3 NIH research awards on record, funded 2008–2014 per NIH RePORTER. The latest:
- Regulation of osteoclast biology by anion exchanger SLC4A2 in mouse and human sys
Brigham and Women'S Hospital
FY2014$374,360R01AR060363 - Myeloid precursors and the microbiome in the osteoimmunology of aging
Brigham and Women'S Hospital
FY2014$204,182R01AG046257 - Regulation of osteoclast biology by anion exchanger SLC4A2 in mouse and human sys
Brigham and Women'S Hospital
FY2013$362,900R01AR060363
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”